Ginkgo Bioworks Holdings, Inc. (DNA) vs Cybin Inc. (HELP)

Ginkgo Bioworks Holdings, Inc. and Cybin Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Cybin Inc. are of similar size ($807.3M and $791.9M). Cybin Inc. has the higher net margin (0.00% vs −219.6%) and the higher return on invested capital (−137.9% vs −161.9%). Across the 13 metrics below, Cybin Inc. leads on 8 and Ginkgo Bioworks Holdings, Inc. on 5.

Valuation

Metric DNA HELP Biotechnology median
P/E n/m n/m 8.50
P/S 4.82 n/m 9.71
P/B 1.52 2.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.99 n/m 9.21
Earnings yield (48.78%) (38.49%) (33.15%)
Free cash flow yield (27.32%) (25.89%) (25.50%)

Profitability

Metric DNA HELP Biotechnology median
Gross margin 68.04% 0.00% 65.16%
Operating margin (231.13%) 0.00% 0.00%
Net margin (219.60%) 0.00% 0.00%
Free cash flow margin (131.57%) 0.00% 0.00%
Return on equity (56.29%) (86.94%) (56.36%)
Return on assets (26.19%) (72.78%) (48.04%)
Return on invested capital (161.94%) (137.88%) 0.00%

Growth

Metric DNA HELP Biotechnology median
Revenue growth (TTM) (37.02%) — 6.02%
EPS growth (last fiscal year) 46.49% (5.72%) 30.26%
Revenue growth, 5-year CAGR 17.29% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNA HELP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.57 10.97 4.72
Net debt to EBITDA 1.63 1.10 0.96

Dividend

Metric DNA HELP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNA HELP Biotechnology median
Market cap 791.92m 807.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack